Stephanie Wong

Insider Reports History

Entity
Individual
Location
343 Oyster Point Blvd #200, South San Francisco, CA
Signature
/s/ Joshua Eizen, Attorney-in-Fact for Stephanie Wong
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie Wong:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Calithera Biosciences, Inc. CHIEF FINANCIAL OFFICER & SECRETARY Common Stock 6.29K $2.43K $0.39 Jan 23, 2023 Direct
Calithera Biosciences, Inc. CHIEF FINANCIAL OFFICER & SECRETARY Common Stock 360 $139 $0.39 Jan 23, 2023 By Trust
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 64.5K Jun 19, 2024 Direct

Insider Reports Filed by Stephanie Wong

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Jun 19, 2024 1 $0 4 Jun 21, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
CALA Calithera Biosciences, Inc. Jan 23, 2023 1 -$141 4 Jan 25, 2023 CHIEF FINANCIAL OFFICER & SECRETARY
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Director
CALA Calithera Biosciences, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 CHIEF FINANCIAL OFFICER & SECRETARY
CALA Calithera Biosciences, Inc. Jan 21, 2022 1 -$2.75K 4 Jan 25, 2022 CHIEF FINANCIAL OFFICER & SECRETARY
CALA Calithera Biosciences, Inc. Jan 4, 2022 1 -$11.9K 4 Jan 6, 2022 CHIEF FINANCIAL OFFICER & SECRETARY
CALA Calithera Biosciences, Inc. Nov 5, 2021 2 -$13.5K 4 Nov 9, 2021 CHIEF FINANCIAL OFFICER & SECRETARY
CALA Calithera Biosciences, Inc. Oct 27, 2021 2 -$86.9K 4 Oct 29, 2021 CHIEF FINANCIAL OFFICER & SECRETARY